Senior Director, Product Management Team Lead (Early Phase) – Foster City at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceuticals, PharmaceuticalsIndustries

Requirements

Experience serving as project manager for early phase biopharma molecules
Deep expertise in early phase product milestones to serve as subject matter expert (SME) for PMs across the Product & Project Management group
Leadership experience to lead a team of product and project management professionals

Responsibilities

Lead a team of product and project management professionals partnering closely with PDM Product Strategy Team Leads to support a diverse portfolio of small molecule and biologics drug candidates across development and commercial stages
Identify and share best practices across the Product Strategy Teams
Serve as SME on early phase PM, drawing upon deep knowledge of early phase product milestones
Use and provide feedback on templated tools and processes for the PDM Team System (e.g., tools for capturing a product’s strategy on a single page)
Work in partnership with PDM Product Strategy Leads to develop, gain approval for, and execute on the product strategy, including key milestones, budgeting, and resource allocation
Support PDM Operations Management’s implementation and iteration of G.Plan (Planisware) and G.Plan product templates
Support the flow of accurate data into PDM milestone planning and resource allocation

Skills

Product Management

Project Management

Team Leadership

Pharmaceutical Development

Manufacturing

Biopharmaceuticals

Early Phase Development

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free